webinar register page

Webinar banner
The Regulatory Landscape of Laboratory Developed Testing Procedures: How we got here, why it’s important, where we’re going, and how you can get involved.
Important conversations are happening in Washington that may limit the ability of physicians to order and perform laboratory developed testing procedures necessary for diagnosing and treating patients. Join us for this free, one-hour webinar to learn about this issue and what you can do to ensure continued access to these critical patient services.

This event, which is jointly hosted by the American Association for Clinical Chemistry (AACC), the American College of Medical Genetics and Genomics (ACMG), the Association for Molecular Pathology (AMP), and the Association of Pathology Chairs (APC) will pull back the curtain on ongoing policy conversations and shed light on how this change will affect the practice of medicine.

Leaders from our organizations will explain the current regulatory process, proposed changes, and the potential impact such changes may have on the clinical laboratory’s ability to continue performing safe, life-saving laboratory developed testing procedures. We will also provide specific suggestions on how AACC, ACMG, AMP, and APC members and others who support patient access to the highest standard of care can influence the outcome of policy deliberations. There will be a live Q&A at the end to answer questions.

Oct 26, 2021 01:00 PM in Eastern Time (US and Canada)

* Required information


Karen Kaul, MD, PhD
Chair of the APC Clinical Service Leaders Committee; Chair of the Department of Pathology @NorthShore University HealthSystem
Dennis Dietzen, PhD
Medical Director of Laboratory Services, St. Louis Children’s Hospital Professor of Pathology & Immunology, and Pediatrics @Washington University School of Medicine, St. Louis MO
Eric Konnick, MD, MS
Co-Chair of the AMP Professional Relations Committee @University of Washington Medical Center
David Flannery, MD, FACMG
ACMG Advocacy and Government Affairs Committee; Director of Telegenetics and Digital Genetics @Center for Personalized Genetic Healthcare, Genomic Medicine Institute, Cleveland Clinic